These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8034681)

  • 1. The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation.
    Cox AD; Garcia AM; Westwick JK; Kowalczyk JJ; Lewis MD; Brenner DA; Der CJ
    J Biol Chem; 1994 Jul; 269(30):19203-6. PubMed ID: 8034681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes.
    Lerner EC; Qian Y; Blaskovich MA; Fossum RD; Vogt A; Sun J; Cox AD; Der CJ; Hamilton AD; Sebti SM
    J Biol Chem; 1995 Nov; 270(45):26802-6. PubMed ID: 7592920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein.
    Cox AD; Hisaka MM; Buss JE; Der CJ
    Mol Cell Biol; 1992 Jun; 12(6):2606-15. PubMed ID: 1375323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
    Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
    Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
    Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
    Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
    Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors.
    Fiordalisi JJ; Johnson RL; Weinbaum CA; Sakabe K; Chen Z; Casey PJ; Cox AD
    J Biol Chem; 2003 Oct; 278(43):41718-27. PubMed ID: 12882980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases.
    Westwick JK; Cox AD; Der CJ; Cobb MH; Hibi M; Karin M; Brenner DA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6030-4. PubMed ID: 8016110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
    Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
    J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for Ras in v-Crk transformation.
    Greulich H; Hanafusa H
    Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist.
    Egozi Y; Weisz B; Gana-Weisz M; Ben-Baruch G; Kloog Y
    Int J Cancer; 1999 Mar; 80(6):911-8. PubMed ID: 10074926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
    Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity.
    Lebowitz PF; Davide JP; Prendergast GC
    Mol Cell Biol; 1995 Dec; 15(12):6613-22. PubMed ID: 8524226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells.
    Kieser A; Seitz T; Adler HS; Coffer P; Kremmer E; Crespo P; Gutkind JS; Henderson DW; Mushinski JF; Kolch W; Mischak H
    Genes Dev; 1996 Jun; 10(12):1455-66. PubMed ID: 8666230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73.
    Smeal T; Binetruy B; Mercola D; Grover-Bardwick A; Heidecker G; Rapp UR; Karin M
    Mol Cell Biol; 1992 Aug; 12(8):3507-13. PubMed ID: 1630458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidomimetic inhibitors of Ras farnesylation and function in whole cells.
    Garcia AM; Rowell C; Ackermann K; Kowalczyk JJ; Lewis MD
    J Biol Chem; 1993 Sep; 268(25):18415-8. PubMed ID: 8360140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
    J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells.
    Grugel S; Finkenzeller G; Weindel K; Barleon B; Marmé D
    J Biol Chem; 1995 Oct; 270(43):25915-9. PubMed ID: 7592779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.